Danaher Corp.

According to a recent report from Jefferies, Danaher (NYSE: DHR) presented at the 2011 Global Healthcare Conference hosted by Jefferies. The key highlights of the presentation touched on AB Sclex, the BEC Integration milestones and metric milestones, and the lack of deterioration in May trends....

In a report released yesterday, Citigroup commented on 3M (NYSE: MMM), United Technologies (NYSE: UTX), and Danaher (NYSE: DHR). On 3M, Citigroup writes, “New CFO David Meline reiterated 3M's playbook for driving organic revenue growth the historical rate of 4% to the 7%-8% target through new...

Deutsche Bank has raised its price target on Danaher (NYSE: DHR) from $60 to $65 reflecting the company's acquisition of Beckman Coulter (NYSE: BEC), which is expected to happen by mid-May. Says Deutsche Bank, in its report, “DHR remains one of our favorite ideas given positive risk/reward vs. our...

Danaher Corporation (NYSE: DHR) is currently known for its strong track record and solid execution, but an ill-timed purchase will cause the company to miss hurdle rates, although the DHR's track record shows it is well positioned to see handsome contributions to earnings growth, JP Morgan reports...

Danaher Corp. (NYSE: DHR) offered guidance late Tuesday that it expects 1st quarter adjusted earnings of between 77 cents and 82 cents per share. The Wall Street consensus is that Danaher Corp. will earn 82 cents per share. Danaher Corp. said that its AB SCIEX deal should contribute another 5 cents...